INTRODUCTION
the quality of life of patients, with minimal surgical complications. Therefore, prognostic factors for spinal metastasis need to be well established in order to reach an appropriate decision on treatment modalities. In general, the survival rate of malignant tumors is largely dependent on the histology of the primary tumor and on the presence of visceral or bone metastases, which include spine metastasis. 12, 13 According to preoperative scoring systems, which serve to determine the surgical strategy for spinal metastases, rapidly growing primary tumors, visceral metastases, and multiple bone metastases are poor preoperative prognostic factors. 12, 13 Tomita, et al. 11, 14 devised a surgical classification of spinal tumors in which intracompartmental, extracompartmental, and multiple lesions are classified according to tumor location inside or outside the vertebral anatomical barrier. Extracompartmental lesions include metastatic tumors that grow into the spinal canal (type 4), extend outside the vertebral body (type 5), and finally spread to the adjacent vertebra(e) (type 6). Multiple-skip spinal metastases represent type 7. In terms of surgical prognostic factors, excellent results have been reported for aggressive total en bloc spondylectomy of intracompartmental tumors; 8, 11, 13 however, few prognostic factors associated with surgical resection are known for spinal metastases that extend beyond the anatomical barriers and compartment (Tomita's classification ≥ type 4).
The aim of this study was to evaluate whether the extent of tumor resection in different primary tumors has an effect on the survival rate and neurological outcomes in patients with advanced spinal metastasis (Tomita's classification ≥ type 4).
Patients
This study was based on a retrospective review of 87 patients (male-to-female ratio, 50 : 37) who had advanced spinal metastasis that extended beyond the anatomical barrier (Tomita's classification ≥ type 4) and who underwent surgical intervention in our institution between August 1997 and February 2008. The mean age of the patients was 57 years (range, 27-76). The average clinical and radiological follow-up period was 24.5 months (range, 1-75 months) ( Table 1) . Surgery was performed in patients who had six months or more of life expectancy, as predicted by oncologists, and who had progressive neurological deficit before, during, or after radiation therapy, and who had intractable pain unresponsive to conservative treatment, and/or spinal instability or vertebral collapse. Some patients were under radio-and/or chemotherapy. If the neurological status or spinal stability of the patient worsened during adjuvant therapy, we considered surgical tumor resection and stabilization of the spinal column. The adjuvant therapy was resumed after confirmation of the complete healing of the surgical wound. Patients who were followed-up for more than one year after the operation and who had a definite primary malignancy lesion were included in this study. Patients who died within one year of the operation were also included. For tumor grading using Tomita's classification, we used bone scintigraphy, preoperative magnetic resonance imaging (MRI) of the entire spine, and computed tomography (CT) of the chest, abdomen, and brain. Exclusion criteria for the study were as follows: spinal metastasis with unknown primary origin, a follow-up period shorter than one year, tumor grade less than type 4 (Tomita's classification), and patients who underwent only biopsy or vertebroplasty.
MATERIALS AND METHODS

Grouping of the patients
The patients were divided into two groups according to the characteristic of the primary malignant tumor:
11,15-18 group 1 included tumors known to respond to adjuvant chemotherapy, radiotherapy, or hormonal therapy (thyroid cancer, breast cancer, prostate cancer, and hematopoietic malignancy); group 2 comprised tumors known not to respond well to adjuvant therapy (lung cancer, hepatocellular carcinoma, pancreas cancer, renal cell cancer, sarcoma, and gastrointestinal cancer).
Groups 1 and 2 were further divided into two subgroups according to the extent of tumor resection (gross total vs. subtotal), which was analyzed using radiological studies and operation records. Gross total resection meant that no tumor mass remained attached to the surrounding normal tissues via thorough debulking and removal of the marginal barriers or total en bloc spondylectomy via a posterioronly or anterior-posterior combined approach. For subtotal resection, laminectomy or internal decompression with/ without instrumentation was performed. Patients with remaining tumor mass at the operated site or at other bone sites (including vertebrae) were classified in the subtotal resection group. As a result of patient grouping according to extent of surgical resection, four subgroups were obtained: group 1, gross total resection (G1GT); group 1, subtotal resection (G1ST); group 2, gross total resection (G2GT); and group 2, subtotal resection (G2ST) ( Table 1 and 2) .
Evaluation of survival rates and neurological status
We analyzed survival periods, grade of metastatic spinal tumor (using Tomita's classification), primary tumor entities, extent of tumor resection, and neurological outcomes. The survival period after operation was calculated to the last date of the follow-up in the patients who were still alive, or to the date of expiration. Statistical analysis of the survival period was performed using the Kaplan-Meier method and the log-rank test was used for statistical comparisons. Significance was achieved if the probability was lower than 5% (p < 0.05).
The neurological outcome was graded before and after surgery using Frankel's grade system. 19 We converted Frankel's grades A, B, C, D, and E into Frankel's points 1, 2, 3, 4, and 5. To compare neurological improvement among the four subgroups, the sum of Frankel's points in each subgroup was expressed as a percentage of the sum of full points: 100× (patients' Frankel points)/5× (number of patients). The neurological status of each subgroup was estimated and compared at the preoperative stage, at one month after surgery, and at last follow-up. Statistical analysis of the neurological outcome was performed using the paired t test. Significance was achieved if the probability was lower than 5% (p < 0.05).
Characteristics of patients in groups 1 and 2
Patient characteristics are listed in Table 1 . Groups 1 and 2 comprised 36 and 51 patients, respectively. The most frequent site of spinal metastasis was the thoracic spine (67% of patients in group 1 and 57% of patients in group 2), followed by the lumbar and cervical spine.
Among the 87 patients, 56 individuals had an isolated spinal metastasis (Tomita classification types 4, 5, or 6), whereas 31 patients had multiple metastases (type 7). In terms of multiple bone metastases, 39% of patients in Gross total resection of tumors was achieved in 28 patients (32%). Gross total resection of spinal tumors was performed more frequently in group 1 than in group 2 (42% vs. 25%). In terms of Tomita's classification, the ratio of gross total resection was 81, 47, and 30% for Tomita's type 4, 5, and 6, respectively (Table 2) .
RESULTS
Tumor origin and pathological diagnosis
Among the 36 patients included in group 1, the most common origin of primary tumors was the bone marrow (12 cases) and breast tissues (12 cases), followed by the thyroid (9 cases) and the prostate (3 cases). Among the 51 patients included in group 2, the lung (12 cases) was the most common primary tumor site, followed by the liver (8 cases) and the kidney (7 cases) ( Table 3 ). Thyroid cancer cases showed the highest one-year survival rate, followed by cancers of the breast and of the bone marrow. In contrast, lung cancer patients had the worst one-year survival rate (17%), followed by liver, colon, and kidney cancers. The most common overall pathologic cell types were adenocarcinoma (23 cases), followed by ductal cell carcinoma (12 cases), plasmacytoma (8 cases), hepatocellular carcinoma (8 cases), and squamous cell carcinoma (7 cases).
Survival rates
Patients in group 1 had a better survival rate than patients in group 2 (p = 0.009) (Fig. 1) . The mean survival period was 28.6 months (range, 2-75) for group 1 and 9.1 months (range, 1-50) for group 2. In group 1, 5 out of 36 patients Kaplan-Meier survival curves of patients with spinal metastases in group 1 (breast cancer, thyroid cancer, hematopoietic malignancy, and prostate cancer) and group 2 (lung cancer, hepatocellular cancer, renal cell cancer, colon cancer, pancreas cancer, rectal cancer, etc) showed a significantly higher survival rate for patients in group 1 (p < 0.01). had died within one year after the operation (one-year survival rate = 86.2%); however, 28 patients were alive at the last follow-up. In group 2, 34 out of 51 patients died within one year after the operation (one-year survival rate = 33.3%) and only 13 patients were alive at the last followup. The average follow-up period for patients in groups 1 and 2 who died was 27.1 and 7.8 months, respectively. The analysis of the survival rate according to the extent of tumor resection revealed that one patient expired six months after the operation and the remaining 14 patients in the G1GT subgroup were alive at the last follow-up. In contrast, 7 out of 21 patients in the G1ST subgroup, expired and 14 patients were alive at the last follow-up. Therefore, the G1GT subgroup showed a significantly better survival rate (p = 0.049) when compared with the G1ST subgroup (Figs. 2 and 3) . The mean survival period was 36.5 months (range, 2-75) for the G1GT subgroup and 28.3 months (range, 1-60) for the G1ST subgroup. In group 2, the extent of tumor resection (G2GT vs. G2ST) did not affect the survival rate of patients (p = 0.115) (Fig. 4) .
Forty-six patients died before the last follow-up: 8 patients (22.2%) in group 1 and 38 patients (74.5%) in group 2. The most common causes of death were major organ metastasis and failure, especially pulmonary and hepatic failure. Six patients expired because of septic shock and one patient expired because of intracerebral hemorrhage. There were no significant differences in the cause of death between groups 1 and 2.
Neurological improvement and local recurrence after gross total resection
In the G1GT subgroup, preoperative neurological status was 89% of full points, which significantly improved to 98% one month after the operation and to 99% at the time of last follow-up (p = 0.008). There was no significant difference in neurological status between one month after the operation and the last follow-up. In the G1ST subgroup, the neurological status at one month after the operation improved slightly from 76 to 80% (p = 0.961), but worsened to 76% at the time of the last follow-up. In the G2GT Survival Rate of Advanced Spinal Metastasis subgroup, the neurological status improved significantly from 89% preoperatively to 96% one month after the operation (p = 0.019), but worsened to 93% at the last follow-up; however, there was a significant improvement in neurological status between the preoperative time point and the time of last follow-up (p = 0.041). In the G2ST subgroup, the neurological status improved from 81% to 85% (p = 0.048) at one month after the operation, but worsened to 78% at the time of last follow-up, which was even worse than the preoperative neurological status (Fig. 5) . Three of the 15 patients in the G1GT subgroup showed a remote recurrence of spinal metastasis, which was removed by secondary operation. There was no local recurrence in the G1GT subgroup at the last follow-up. Four of the 13 patients in the G2GT subgroup had a local recurrence of spinal tumor and progressive worsening of neurological status.
In the 1980s, patients with spinal metastases were considered to be in the terminal stage of disease, as about half of them died within six months of spinal surgery. 20 Recently, however, the survival rate of malignant spinal metastases has rapidly improved because of early detection of metastases and multimodality treatment, which includes the development of surgical techniques. Life expectancy, the general condition of a patient, the characteristics of the primary tumor, and the resectability of metastatic tumor masses should be considered in the surgical treatment of advanced metastatic spinal tumors. The prognostic parameters suggested for metastatic spine tumors include the general condition of the patient, number of spinal and extraspinal metastases, primary site of the cancer, visceral metastasis, and severity of spinal cord palsy. [11] [12] [13] 21 Among them, the presence of spinal tumor metastasis and spinal cord palsy are controllable surgical factors, if efficient total resection of the tumor mass can be achieved.
Our present results showed that the survival rate in cases with advanced spinal metastasis was affected largely by the pathological characteristics of the primary tumors. Before and/or after spinal tumor surgery, the primary tumor was managed medically or surgically by each responsible department. Some patients died because of major organ metastasis, even though there was no recurrence at the site of spinal surgery. It seems that 100% of thyroid cancer patients survived at the last follow-up because curative tumor resection was possible in most cases. We think that complete control of the primary tumor is as important for long-term survival as the pathological type of the tumor. Previous studies addressing the survivability of patients showed a favorable prognosis for cases with spinal metastases, 11, 13, 22, 23 myeloma, breast, thyroid, and prostate cancers, while patients with cancers of the lung, liver, and gastrointestinal tract had poor prognosis. Visceral metastases at the time of the first surgical treatment of a bony metastasis are significantly correlated with survival time, 24, 25 and, as shown in this study, major organ failure is the most common cause of death. Cancers of the lung and liver, which were classified as tumors not responding well to adjuvant therapy (group 2) in this study, are the most common metastatic spinal tumors, and the primary sites themselves represent the beginning of major visceral organ failure. In renal cell cancer, the prognosis ranges from favorable to poor. 13, 22, 26 In the case of intracompartmental metastasis, a long survival time would be expected after total en bloc spondylectomy. 11, 13 As all the cases in our series were extracompartmental spinal metastasis, renal cell cancer (Tomita's classification ≥ type 4) was classified as group 2. Nevertheless, the renal cell cancer cases analyzed here exhibited a better survival rate when compared with lung, liver, or colon cancer cases. Our results seem to indicate that the characteristics and controllability of the primary tumor are of vital importance in the decisionmaking process regarding the goal of the surgery (i.e., gross total removal or palliative decompression). Overtreatment of the patients by aggressive resection to obtain minimal surgical benefits must be avoided; however, aggressive total tumor resection should be a surgical goal for patients who have spinal metastasis from a favorable primary tumor, even if the metastasis extends beyond the vertebral compartment. Neurological grade assessed by conversion of Frankel's grade system to a point system. The neurological status of the G1GT and G2GT subgroups was significantly improved one month after surgery and at the last follow-up. In contrast, the G1ST and G2ST subgroups improved shortly after surgery but worsened at the time of last follow-up; in particular, the neurological status of the G2ST subgroup became even worse than at the preoperative stage. *Significantly improved neurological status when compared with the preoperative stage (p < 0.05). � Significantly worsened neurological status when compared with the preoperative stage (p < 0.05).
